002349 精華製藥
按盤價 
8.000 +0.620 (+8.401%)
8.000 +0.620 (+8.401%) | 2024/06 - 中期 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 5.471 | 10.224 | 9.154 | 7.400 | 5.609 |
| 總資產報酬率 ROA (%) | 4.252 | 7.956 | 6.802 | 5.058 | 3.641 |
| 投入資產回報率 ROIC (%) | 5.361 | 9.909 | 8.479 | 6.490 | 4.611 | 邊際利潤分析 |
| 銷售毛利率 (%) | 50.849 | 48.693 | 46.733 | 46.557 | 48.311 |
| 營業利潤率 (%) | 25.681 | 21.885 | 15.987 | 13.293 | 4.939 |
| 息稅前利潤/營業總收入 (%) | 21.673 | 20.278 | 14.950 | 13.215 | 6.280 |
| 淨利潤/營業總收入 (%) | 21.506 | 18.288 | 13.495 | 10.307 | 2.179 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 97.331 | 99.047 | 95.843 | 102.590 | 357.050 |
| 價值變動淨收益/利潤總額(%) | 2.742 | 2.145 | 11.772 | 17.573 | 16.265 |
| 營業外收支淨額/利潤總額(%) | -1.343 | -0.352 | -0.508 | -0.904 | 0.729 | 償債能力分析 |
| 流動比率 (X) | 6.687 | 5.493 | 4.381 | 2.644 | 2.688 |
| 速動比率 (X) | 5.711 | 4.688 | 3.602 | 2.109 | 2.106 |
| 資產負債率 (%) | 10.035 | 11.954 | 13.749 | 19.654 | 0.212 |
| 帶息債務/全部投入資本 (%) | 1.011 | 1.536 | 2.917 | 9.856 | 12.913 |
| 股東權益/帶息債務 (%) | 9,726.242 | 6,358.825 | 3,295.692 | 904.355 | 667.826 |
| 股東權益/負債合計 (%) | 784.281 | 642.053 | 574.080 | 355.719 | 314.887 |
| 利息保障倍數 (X) | -5.910 | -13.244 | -15.630 | 327.037 | 4.813 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 70.028 | 55.716 | 49.519 | 59.537 | 71.712 |
| 存貨周轉天數 (天) | 148.779 | 138.913 | 135.503 | 156.490 | 177.771 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 30/09/2024 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
